Literature DB >> 27910172

IMAGING DIAGNOSIS-IMAGING AND HISTOPATHOLOGIC CHARACTERISTICS OF A VERTEBRAL HAMARTOMA IN A CAT.

Frances E Taylor-Brown1, Christopher R Lamb1, Henny Martineau2, Clare Muir2, Elsa Beltran1.   

Abstract

A 9-month-old domestic shorthair cat had progressive ambulatory paraparesis, proprioceptive ataxia, and thoracolumbar hyperesthesia. An extradural mass affecting the left pedicle and lamina of the second lumbar vertebra (L2) causing marked spinal cord impingement was identified in magnetic resonance (MR) images. The mass was predominantly calcified in computed tomographic (CT) images. A hemilaminectomy was performed to resect the mass. Clinical signs were greatly improved at 12-month follow-up. The histopathologic diagnosis was vascular hamartoma. To our knowledge, this is the first report describing the MR characteristics of a vascular hamartoma associated with the vertebral column.
© 2016 American College of Veterinary Radiology.

Entities:  

Keywords:  cat; hamartoma; paraparesis; spinal disease

Mesh:

Year:  2016        PMID: 27910172     DOI: 10.1111/vru.12454

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  3 in total

1.  Spinal epidural arteriovenous fistula in 3 cats.

Authors:  Naoko Yayoshi; Karin Yoshida; Masashi Terao; Tsuyoshi Ozawa; Hiroaki Kamishina; Fumitaka Takahashi; Yasushi Hara; Yoshihiko Yu; Daisuke Hasegawa
Journal:  J Vet Intern Med       Date:  2022-08-19       Impact factor: 3.175

2.  Repeated surgical treatment and long-term outcome of a cat with vertebral vascular hamartoma.

Authors:  Daisuke Ito; Naoko Shiozawa; Naoki Sekiguchi; Chieko Ishikawa; Nick D Jeffery; Masato Kitagawa
Journal:  J Vet Med Sci       Date:  2020-04-16       Impact factor: 1.267

3.  Mandibular vascular hamartoma in a cat.

Authors:  Satoshi Takagi; Yumiko Kagawa; Kiwamu Hanazono; Shoko Murakami; Tatsuya Deguchi; Yusuke Izumi; Kenji Hosoya; Sangho Kim; Masahiro Okumura
Journal:  J Vet Med Sci       Date:  2018-07-13       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.